Conversion of oral alfacalcidol to oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patientsSandrine Rauscher, Michel Vallée, Georges Ouellet et al.|International Urology and Nephrology|2016Cited by 10
Aminoglycosides administration at the end of the hemodialysis session: A pharmacokinetic failure?Jean-François Tessier, Michel Vallée, Jean-Phillipe Lafrance et al.|International Journal of Clinical Pharmacology and Therapeutics|2020Cited by 2
Pharmacokinetics of Tobramycin Administered at the Beginning of Intermittent Hemodialysis Session (ESRD Study)Marjolaine Giroux, Jean‐Philippe Lafrance, Nicolas Bouchard et al.|Canadian Journal of Kidney Health and Disease|2021Cited by 2